ERBB2 and breast cancer: In addition to PIK3CA, the PI3K pathway harbors diverse alterations in BC, including mutations in receptor tyrosine kinases (RTKs), such as HER2 (ERBB2) and fibroblast growth factor receptor (FGFR)1, as well as in the AKT1 and PTEN genes.